sxi20231231_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-07233

STANDEX INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

31-0596149

(State of incorporation)

(IRS Employer Identification No.)

23 Keewaydin drive, Salem, New Hampshire	03079
(Address of principal executive offices)	(Zip Code)

(603) 893-9701

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $1.50 Per Share	SXI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒			Accelerated filer ☐
Non-accelerated filer ☐			Smaller reporting company ☐
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of Registrant's Common Stock outstanding on January 31, 2024 was 11,870,622.

STANDEX INTERNATIONAL CORPORATION

INDEX

		Page No.
PART I. FINANCIAL INFORMATION:

Item 1.

	Condensed Consolidated Balance Sheets as of December 31, 2023 and June 30, 2023 (unaudited)	3

	Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2023 and 2022 (unaudited)	4

	Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended December 31, 2023 and 2022 (unaudited)	5

	Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended December 31, 2023 and 2022 (unaudited)	6

	Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2023 and 2022 (unaudited)	8

	Notes to Unaudited Condensed Consolidated Financial Statements	9

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	27

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	39

Item 4.	Controls and Procedures	40

PART II. OTHER INFORMATION:

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41

Item 5.	Other Information	41

Item 6.	Exhibits	42

	*December 31,*			*June 30,*
(In thousands, except per share data)	*2023*			*2023*
ASSETS
Current assets:
Cash and cash equivalents	$	142,424		$	195,706
Accounts receivable, less allowance for credit losses of $2,753 and $2,788 at December 31, 2023 and June 30, 2023, respectively		125,575			123,440
Inventories		98,592			98,537
Prepaid expenses and other current assets		65,572			64,739
Income taxes receivable		3,836			831
Total current assets		435,999			483,253

Property, plant, and equipment, net		132,599			130,937
Intangible assets, net		82,726			75,651
Goodwill		280,337			264,821
Deferred tax asset		14,027			14,602
Operating lease right-of-use asset		34,026			33,273
Other non-current assets		25,347			22,392
Total non-current assets		569,062			541,676

Total assets	$	1,005,061		$	1,024,929

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	63,883		$	68,601
Accrued liabilities		56,062			62,031
Income taxes payable		10,597			10,335
Total current liabilities		130,542			140,967

Long-term debt		148,659			173,441
Operating lease long-term liabilities		26,080			25,774
Accrued pension and other non-current liabilities		79,209			77,298
Total non-current liabilities		253,948			276,513

Contingencies (Note 15)

Stockholders' equity:
Common stock, par value $1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 11,783,199 and 11,744,991 shares outstanding at December 31, 2023 and June 30, 2023		41,976			41,976
Additional paid-in capital		101,198			100,555
Retained earnings		1,058,069			1,027,279
Accumulated other comprehensive loss		(155,561	)		(158,477	)
Treasury shares: 16,201,079 and 16,239,287 shares at December 31, 2023 and June 30, 2023		(425,111	)		(403,884	)
Total stockholders' equity		620,571			607,449

Total liabilities and stockholders' equity	$	1,005,061		$	1,024,929

	*Three Months Ended*						*Six Months Ended*
	*December 31,*						*December 31,*
(In thousands, except per share data)	*2023*			*2022*			*2023*			*2022*
Net sales	$	178,400		$	187,789		$	363,174		$	368,389
Cost of sales		106,737			115,469			218,876			227,816
Gross profit		71,663			72,320			144,298			140,573
Selling, general, and administrative expenses		43,276			43,713			86,861			84,802
(Gain) loss on sale of business		-			-			(274	)		-
Restructuring costs		1,360			511			3,266			1,093
Acquisition related costs		1,195			174			1,696			466
Other operating (income) expense, net		-			116			-			116
Total operating expenses		45,831			44,514			91,549			86,477
Income from operations		25,832			27,806			52,749			54,096
Interest expense		1,019			1,566			2,295			2,753
Other non-operating (income) expense, net		332			(70	)		1,178			948
Income from continuing operations before income taxes		24,481			26,310			49,276			50,395
Provision for income taxes		5,409			6,226			11,312			11,995
Income from continuing operations		19,072			20,084			37,964			38,400
Income (loss) from discontinued operations, net of tax		(201	)		(41	)		(279	)		(87	)
Net income	$	18,871		$	20,043		$	37,685		$	38,313

Basic earnings (loss) per share:
Continuing operations	$	1.62		$	1.69		$	3.22		$	3.25
Discontinued operations		(0.02	)		-			(0.02	)		(0.01	)
Total	$	1.60		$	1.69		$	3.20		$	3.24
Diluted earnings (loss) per share:
Continuing operations	$	1.61		$	1.69		$	3.19		$	3.22
Discontinued operations		(0.02	)		-			(0.02	)		(0.01	)
Total	$	1.59		$	1.69		$	3.17		$	3.21

Weighted average number of shares:
Basic		11,791			11,852			11,762			11,833
Diluted		11,858			11,917			11,891			11,930

	*Three Months Ended*						*Six Months Ended*
	*December 31,*						*December 31,*
(In thousands)	*2023*			*2022*			*2023*			*2022*
Net income	$	18,871		$	20,043		$	37,685		$	38,313
Other comprehensive income (loss):
Defined benefit pension plans:
Actuarial gains (losses) and other changes in unrecognized costs, net of tax	$	(133	)	$	(82	)	$	(12	)	$	14
Amortization of unrecognized costs, net of tax		597			710			1,193			1,420
Derivative instruments:
Change in unrealized gains (losses), net of tax		(675	)		(170	)		110			2,627
Amortization of unrealized gains (losses) into interest expense, net of tax		(1,280	)		(234	)		(2,781	)		(80	)
Foreign currency translation gains (losses), net of tax		13,506			23,649			4,406			2,105
Other comprehensive income (loss), net of tax	$	12,015		$	23,873		$	2,916		$	6,086
Comprehensive income	$	30,886		$	43,916		$	40,601		$	44,399

									*Accumulated Other*
For the three month period ended			*Additional*						*Comprehensive*									*Total*
December 31, 2023	*Common*		*Paid-in*			*Retained*			*Income*			*Treasury Stock*						*Stockholders’*
(in thousands, except as specified)	*Stock*		*Capital*			*Earnings*			*(Loss)*			*Shares*			*Amount*			*Equity*
Balance, September 30, 2023	$	41,976	$	98,713		$	1,042,695		$	(167,576	)		16,189		$	(421,169	)	$	594,639
Stock issued under incentive compensation plans and employee purchase plans		-		(145	)		-			-			(22	)		567			422
Stock-based compensation		-		2,630			-			-			-			-			2,630
Treasury stock acquired		-		-			-			-			34			(4,509	)		(4,509	)
Comprehensive income:
Net income		-		-			18,871			-			-			-			18,871
Foreign currency translation adjustment		-		-			-			13,506			-			-			13,506
Pension, net of tax of $0.2 million		-		-			-			464			-			-			464
Change in fair value of derivatives, net of tax of $0.7 million		-		-			-			(1,955	)		-			-			(1,955	)
Dividends declared ($0.30 per share)		-		-			(3,497	)		-			-			-			(3,497	)
Balance, December 31, 2023	$	41,976	$	101,198		$	1,058,069		$	(155,561	)		16,201		$	(425,111	)	$	620,571

For the three month period ended December 31, 2022
(in thousands, except as specified)
Balance, September 30, 2022	$	41,976	$	91,446		$	916,549		$	(171,099	)		16,119		$	(387,182	)	$	491,690
Stock issued under incentive compensation plans and employee purchase plans		-		(222	)		-			-			(16	)		380			158
Stock-based compensation		-		2,135			-			-			-			-			2,135
Treasury stock acquired		-		-			-			-			50			(5,123	)		(5,123	)
Comprehensive income:
Net income		-		-			20,043			-			-			-			20,043
Foreign currency translation adjustment		-		-						23,649			-			-			23,649
Pension, net of tax of $0.2 million		-		-			-			628			-			-			628
Change in fair value of derivatives, net of tax of $0.1 million		-		-			-			(404	)		-			-			(404	)
Dividends declared ($0.28 per share)		-		-			(3,359	)		-			-			-			(3,359	)
Balance, December 31, 2022	$	41,976	$	93,359		$	933,233		$	(147,226	)		16,153		$	(391,925	)	$	529,417

									*Accumulated Other*
For the six month period ended			*Additional*						*Comprehensive*									*Total*
December 31, 2023	*Common*		*Paid-in*			*Retained*			*Income*			*Treasury Stock*						*Stockholders’*
(in thousands, except as specified)	*Stock*		*Capital*			*Earnings*			*(Loss)*			*Shares*			*Amount*			*Equity*
Balance, June 30, 2023	$	41,976	$	100,555		$	1,027,279		$	(158,477	)		16,239		$	(403,884	)	$	607,449
Stock issued under incentive compensation plans and employee purchase plans		-		(4,181	)		-			-			(210	)		5,370			1,189
Stock-based compensation		-		4,824			-			-			-			-			4,824
Treasury stock acquired		-		-			-			-			172			(26,597	)		(26,597	)
Comprehensive income:
Net income		-		-			37,685			-			-			-			37,685
Foreign currency translation adjustment		-		-			-			4,406			-			-			4,406
Pension, net of tax of $0.4 million		-		-			-			1,181			-			-			1,181
Change in fair value of derivatives, net of tax of $0.9 million		-		-			-			(2,671	)		-			-			(2,671	)
Dividends declared ($0.58 per share)		-		-			(6,895	)		-			-			-			(6,895	)
Balance, December 31, 2023	$	41,976	$	101,198		$	1,058,069		$	(155,561	)		16,201		$	(425,111	)	$	620,571

For the six month period ended December 31, 2022
(in thousands, except as specified)
Balance, June 30, 2022	$	41,976	$	91,200		$	901,421		$	(153,312	)		16,160		$	(381,942	)	$	499,343
Stock issued under incentive compensation plans and employee purchase plans		-		(2,540	)		-			-			(147	)		3,534			994
Stock-based compensation		-		4,699			-			-			-			-			4,699
Treasury stock acquired		-		-			-			-			140			(13,517	)		(13,517	)
Comprehensive income:																			-
Net income		-		-			38,313			-			-			-			38,313
Foreign currency translation adjustment		-		-			-			2,105			-			-			2,105
Pension, net of tax of $0.5 million		-		-			-			1,434			-			-			1,434
Change in fair value of derivatives, net of tax of $0.8 million		-		-			-			2,547			-			-			2,547
Dividends declared ($0.54 per share)		-		-			(6,501	)		-			-			-			(6,501	)
Balance, December 31, 2022	$	41,976	$	93,359		$	933,233		$	(147,226	)		16,153		$	(391,925	)	$	529,417

	*Six Months Ended*
	*December 31,*
(In thousands)	*2023*			*2022*
Cash flows from operating activities
Net income	$	37,685		$	38,313
Income (loss) from discontinued operations		(279	)		(87	)
Income from continuing operations		37,964			38,400
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		13,969			13,966
Stock-based compensation		4,824			4,699
Non-cash portion of restructuring charge		346			(1,183	)
Gain on sale of business		(274	)		-
Contributions to defined benefit plans		(1,541	)		(101	)
Changes in operating assets and liabilities, net		(15,121	)		(28,690	)
Net cash provided by (used in) operating activities - continuing operations		40,167			27,091
Net cash provided by (used in) operating activities - discontinued operations		(422	)		(51	)
Net cash provided by (used in) operating activities		39,745			27,040
Cash flows from investing activities
Expenditures for property, plant, and equipment		(8,587	)		(11,028	)
Proceeds from sale of business		274			-
Expenditures for acquisitions, net of cash acquired		(29,229	)		-
Other investing activity		-			98
Net cash provided by (used in) investing activities		(37,542	)		(10,930	)
Cash flows from financing activities
Proceeds from borrowings		-			28,500
Payments of debt		(25,000	)		(16,000	)
Contingent consideration payment		-			(1,167	)
Activity under share-based payment plans		1,189			994
Purchases of treasury stock		(26,650	)		(13,517	)
Cash dividends paid		(6,840	)		(6,399	)
Net cash provided by (used in) financing activities		(57,301	)		(7,589	)
Effect of exchange rate changes on cash and cash equivalents		1,816			129
Net change in cash and cash equivalents		(53,282	)		8,650
Cash and cash equivalents at beginning of year		195,706			104,844
Cash and cash equivalents at end of period	$	142,424		$	113,494

Supplemental Disclosure of Cash Flow Information:
Cash paid during the year for:
Interest	$	2,222		$	2,225
Income taxes, net of refunds	$	14,010		$	12,822

Statements contained in this Quarterly Report that are not based on historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as “should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company’s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change. Factors that may affect our operating results are described in the Risk Factors section in the Annual Reports we file with the SEC. Please refer to our most recent discussion of risk factors included in the fiscal year 2023 10-K filed with the SEC on August 5, 2023.

We are a diversified industrial manufacturer with leading positions in a variety of products and services that are used in diverse commercial and industrial markets. Headquartered in Salem, New Hampshire, we have six operating segments aggregated into five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. Two operating segments are aggregated into Specialty Solutions. Our businesses work in close partnership with our customers to deliver custom solutions or engineered components that solve their unique and specific needs, an approach we call "Customer Intimacy".

Our long-term business strategy is to create, improve, and enhance shareholder value by building more profitable, focused industrial platforms through our Standex Value Creation System. This methodology employs four components: Balanced Performance Plan, Growth Disciplines, Operational Excellence, and Talent Management and provides both a company-wide framework and tools used to achieve our goals. We intend to continue investing organically and inorganically in high margin and growth businesses using this balanced and proven approach.

It is our objective to grow larger and more profitable business units through a commitment to both organic and inorganic initiatives. We have a particular focus on identifying and investing in businesses, new products and new applications that complement our existing products and will increase our overall scale, global presence and capabilities. We continue to execute on acquisitions where strategically aligned with our businesses and where the opportunity meets our investment metrics. We have divested, and likely will continue to divest, businesses that we feel are not strategic or do not meet our growth and return expectations. We also continue to monitor our ability to participate in any governmental assistance programs available to us in each of our global locations and participate in these programs as available and appropriate.

As a result of our portfolio moves over the past several years, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition. The narrowing of the portfolio allows for greater management focus on driving operational disciplines and positions us well to use our cash flow from operations to invest selectively in our ongoing pipeline of organic and inorganic opportunities.

The Company’s strong historical cash flow has been a cornerstone for funding our capital allocation strategy. We use cash flow generated from operations to fund investments in capital assets to upgrade our facilities, improve productivity and lower costs, invest in the strategic growth programs described above, including organic growth and acquisitions, and to return cash to our shareholders through payment of dividends and stock buybacks.

Restructuring expenses reflect costs associated with our efforts of continuously improving operational efficiency and expanding globally in order to remain competitive in our end user markets. We incur costs for actions to size our businesses to a level appropriate for current economic conditions, improve our cost structure, enhance our competitive position and increase operating margins. Such expenses include costs for moving facilities to locations that allow for lower fixed and variable costs, external consultants who provide additional expertise starting up plants after relocation, downsizing operations because of changing economic conditions, and other costs resulting from asset redeployment decisions. Shutdown costs include severance, benefits, stay bonuses, lease and contract terminations, asset write-downs, costs of moving fixed assets, and moving and relocation costs. Vacant facility costs include maintenance, utilities, property taxes and other costs.

Because of the diversity of the Company’s businesses, end user markets and geographic locations, management does not use specific external indices to predict the future performance of the Company, other than general information about broad macroeconomic trends. Each of our individual business units serves niche markets and attempts to identify trends other than general business and economic conditions which are specific to its business and which could impact its performance. Those units report pertinent information to senior management, which uses it to the extent relevant to assess the future performance of the Company. A description of any such material trends is described below in the applicable segment analysis.

We monitor a number of key performance indicators (“KPIs”) including net sales, income from operations, backlog, effective income tax rate, gross profit margin, and operating cash flow. A discussion of these KPIs is included below. We may also supplement the discussion of these KPIs by identifying the impact of foreign exchange rates, acquisitions, and other significant items when they have a material impact on a specific KPI.

We believe the discussion of these items provides enhanced information to investors by disclosing their impact on the overall trend which provides a clearer comparative view of the KPI, as applicable. For discussion of the impact of foreign exchange rates on KPIs, we calculate the impact as the difference between the current period KPI calculated at the current period exchange rate as compared to the KPI calculated at the historical exchange rate for the prior period. For discussion of the impact of acquisitions, we isolate the effect on the KPI amount that would have existed regardless of such acquisition. Sales resulting from synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion.

Net sales decreased in the second quarter of fiscal year 2024 by $9.4 million or 5.0%, when compared to the prior year quarter. Organic sales decreased $14.0 million, or 7.4%, due to transitory headwinds in several of our end markets, primarily from unfavorable project timing in our Engineering Technologies group and lower demand in our Specialty segment, partially offset by strong demand in the Engraving segment. Organic sales included $21.0 million in the period attributed to fast growth markets. Foreign currency also positively impacted sales by $1.1 million, or 0.6%. The acquisition of Minntronix positively impacted sales by $10.7 million, or 5.6%, partially offset by the impact on sales associated with the divestiture of Procon of $7.1 million, or 3.8%.

Net sales decreased in the six months ended December 31, 2023 by $5.2 million or 1.4%, when compared to the prior year period. Organic sales decreased $9.5 million, or 2.6%, due to transitory headwinds in several of our end markets, primarily from unfavorable project timing in our Engineering Technologies group and lower demand in our Specialty segment, partially offset by pricing actions and strong demand in the Engraving segment. Organic sales included $40.9 million in the period attributed to fast growth markets. Foreign currency also positively impacted sales by $1.9 million, or 0.5%. The acquisition of Minntronix positively impacted sales by $18.2 million, or 4.9%, offset by the impact on sales associated with the divestiture of Procon of $15.7 million, or 4.2%.

Gross profit in the second quarter of fiscal year 2024 decreased to $71.7 million, or a gross margin of 40.2% as compared to $72.3 million, or a gross margin of 38.5%, in the second quarter of fiscal year 2023. The gross profit margin increase was a result of pricing actions, productivity initiatives and contribution from the Minntronix acquisition, partially offset by the divestiture of the Procon business and organic sales decreases of $14.0 million.

Gross profit in the six months ended December 31, 2023 increased to $144.3 million, or a gross margin of 39.7% as compared to $140.6 million, or a gross margin of 38.2%, in the prior year period. The gross profit margin increase was a result of pricing actions, productivity initiatives and contribution from the Minntronix acquisition, partially offset by the divestiture of the Procon business and organic sales decreases of $9.5 million.

Selling, General, and Administrative (“SG&A”) expenses for the second quarter of fiscal year 2024 were $43.3 million, or 24.3% of sales, compared to $43.7 million, or 23.3% of sales, during the prior year quarter. SG&A expenses during the quarter were primarily impacted by a reduction in selling and marketing expenses partially offset by increased research and development spending to drive future product initiatives.

Selling, General, and Administrative (“SG&A”) expenses for the six months ended December 31, 2023 were $86.9 million, or 23.9% of sales, compared to $84.8 million, or 23.0% of sales, during the prior year period. SG&A expenses during the period were primarily impacted by increased research and development spending and partially offset by a reduction in selling and marketing expenses.

We incurred restructuring expenses of $1.4 million and $3.3 million in the second quarter of fiscal year 2024 and the six months ended December 31, 2023, respectively, primarily related to productivity improvements, facility rationalization activities, and global headcount reductions within our Engraving, Electronics and Engineering Technologies segments as well as the Corporate headquarters.

We expect to incur restructuring costs of approximately $3.5 million throughout the remainder of fiscal year 2024, as we continue to focus our efforts to reduce cost and improve productivity across our businesses, particularly through headcount reductions and productivity initiatives.

We incurred acquisition related expenses of $1.2 million and $1.7 million in the second quarter of fiscal year 2024 and the six months ended December 31, 2023, respectively. Acquisition related expenses typically consist of due diligence, integration, and valuation expenses incurred in connection with recent or pending acquisitions.

We recorded a pre-tax gain on sale of the Procon business of $62.1 million for fiscal year 2023. In the first quarter of fiscal year 2024, we recorded an additional $0.3 million gain on the sale related to closing cash adjustments. The sale transaction and financial results of Procon are classified as continuing operations in the Consolidated Financial Statements.

Income from operations for the second quarter of fiscal year 2024 was $25.8 million, compared to $27.8 million during the prior year quarter. The decrease of $2.0 million, or 7.1%, is primarily due to organic sales decreases and increased investment in research and development spending, restructuring and acquisition related costs partially offset by pricing actions, along with cost reduction activities and productivity improvement initiatives.

Income from operations for the six months ended December 31, 2023 was $52.7 million, compared to $54.1 million during the prior year period. The decrease of $1.3 million, or 2.5%, is primarily due to organic sales decreases and increased investment in research and development spending, restructuring and acquisition related costs partially offset by pricing actions, along with cost reduction activities and productivity improvement initiatives.

Interest expense for the second quarter of fiscal year 2024 was $1.0 million, a 34.9% decrease from interest expense of $1.6 million during the prior year quarter. Interest expense for the six months ended December 31, 2023 was $2.3 million, a 16.6% decrease from interest expense of $2.8 million during the prior year period. Our effective interest rate for the six months ended December 31, 2023 was 2.65%.

Our effective tax rate from continuing operations for the second quarter of fiscal year 2024 and for the six months ended December 31, 2023 was 22.1% and 23.0%, respectively, compared with 23.7% and 23.8% for the prior year quarter and prior year period, respectively. The tax rate was impacted in the current period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes, and (iv) federal research and development tax credits. The tax rate was impacted in the prior period by the following items: (i) a discrete tax benefit related to equity compensation, (ii) the jurisdictional mix of earnings and (iii) foreign withholding taxes.

On July 31, 2023, we completed our acquisition of Minntronix, Inc. (“Minntronix”). We accounted for the Minntronix purchase under the acquisition method in accordance with ASC Topic 805, Business Combinations. Accordingly, the purchase price was allocated to the fair value of the assets acquired, including identifiable intangible assets, and the liabilities assumed as of the closing date. Goodwill resulting from the difference between the fair value of the assets acquired and the fair value of the liabilities assumed is not amortizable for book or tax purposes. Although the acquisition was nontaxable, the transaction gave rise to certain temporary differences for which deferred taxes have been recognized. The results of operations for the Minntronix acquisition have been included in our consolidated financial results beginning on the July 31, 2023 closing date.

Backlog includes all active or open orders for goods and services. Backlog also includes any future deliveries based on executed customer contracts, so long as such deliveries are based on agreed upon delivery schedules. Backlog orders are not necessarily an indicator of future sales levels because of variations in lead times and customer production demand pull systems, with the exception of Engineering Technologies. Customers may delay delivery of products or cancel orders prior to shipment, subject to possible cancellation penalties. Due to the nature of long-term agreements in the Engineering Technologies segment, the timing of orders and delivery dates can vary considerably resulting in significant backlog changes from one period to another.

Total backlog realizable under one year decreased $59.3 million, or 22.1%, to $209.3 million at December 31, 2023, from $268.6 million at December 31, 2022.

Looking forward to the remainder of fiscal year 2024, we expect to be well positioned to build on fiscal year 2023 and the six months ended December 31, 2023 momentum, with anticipated continued improvement in key financial metrics, supported by productivity initiatives.

Net sales in the second quarter of fiscal year 2024 increased $6.9 million, or 9.5%, when compared to the prior year quarter. The acquisition of Minntronix in the first quarter of fiscal year 2024 added $10.7 million, or 14.7%, in sales for the second quarter of fiscal year 2024. The organic sales decrease of $4.2 million, or 5.7%, was partially offset by foreign currency impacts of $0.4 million, or 0.5% compared to the prior year quarter. Organic sales were impacted by continued softness in China and Europe, primarily in the appliances and general industrial end markets.

Income from operations in the second quarter of fiscal year 2024 decreased by $1.1 million, or 6.6%, when compared to the prior year quarter. The operating income decrease was the result of lower organic sales and a change in product mix, partially offset by contribution from the Minntronix acquisition, pricing actions and productivity initiatives.

Net sales in the six months ended December 31, 2023 increased $13.4 million, or 9.0%, when compared to the prior year period. The acquisition of Minntronix in the first quarter of fiscal year 2024 added $18.2 million, or 12.3%, in sales for the six months ended December 31, 2023. The organic sales decrease of $5.5 million, or 3.7%, was partially offset by foreign currency impacts of $0.6 million, or 0.4% compared to the prior year period. Organic sales were impacted by continued softness in China and Europe, primarily in appliances and general industrial end markets.

Income from operations in the six months ended December 31, 2023 decreased by $2.9 million, or 8.3%, when compared to the prior year period. The operating income decrease was the result of lower sales, a change in product mix and foreign currency impacts, partially offset by contribution from the Minntronix acquisition, pricing actions and productivity initiatives.

In the third quarter of fiscal year 2024, on a sequential basis, we expect slightly to moderately higher revenue and slightly higher operating margin due to higher volume and contribution from the pending acquisition of Sanyu.

Net sales in the second quarter of fiscal year 2024 increased by $3.2 million, or 8.4%, when compared to the prior year quarter. Organic sales increased by $2.5 million, or 6.7%, due to strong demand in Europe. Foreign currency positive impacts contributed $0.6 million, or 1.7%.

Income from operations in the second quarter of fiscal year 2024 increased by $2.5 million, or 39.8%, when compared to the prior year quarter. The operating income increase was driven by organic sales increases and previously announced productivity initiatives.

Net sales in the six months ended December 31, 2023 increased by $8.9 million, or 12.3%, when compared to the prior year period. Organic sales increased by $7.9 million, or 10.9%, due to strong demand in Europe and growth in soft trim applications in Asia. Foreign currency positive impacts contributed $1.0 million, or 1.3%.

Income from operations in the six months ended December 31, 2023 increased by $4.3 million, or 35.0%, when compared to the prior year period. The operating income increase was driven by organic sales increases and ongoing productivity initiatives.

In the third quarter of fiscal year 2024, on a sequential basis, we expect meaningfully lower revenue and operating margin due to the seasonal impact of the Chinese New Year on project timing and fewer new platform rollouts in North America.

Net sales in the second quarter of fiscal year 2024 decreased when compared to the prior year quarter, reflecting lower demand for COVID vaccine storage units from retail pharmacies, slightly offset by an increase in new product sales.

Income from operations in the second quarter of fiscal year 2024 increased $0.1 million, or 2.0%, when compared to the prior year quarter. The small increase is driven by lower oceanic freight costs and productivity initiatives offset by lower volume.

Net sales in the six months ended December 31, 2023 decreased when compared to the prior year period, reflecting lower demand for COVID vaccine storage units from retail pharmacies, slightly offset by higher demand in research and academic end market and an increase in new product sales.

Income from operations in the six months ended December 31, 2023 increased $1.3 million, or 16.4%, when compared to the prior year period. The increase is primarily driven by pricing initiatives and lower oceanic freight costs, partially offset by lower volume.

In the third quarter of fiscal year 2024, on a sequential basis, we expect slightly higher revenue and similar to slightly higher operating margin.

Net sales in the second quarter of fiscal year 2024 decreased by $4.3 million, or 17.8%, when compared to the prior year quarter. Organic sales decreased by $4.4 million, or 18.1% partially offset by foreign currency impacts of $0.1 million, or 0.3%, as compared to the prior year quarter. The net sales decrease was due to timing of projects partially offset by pricing.

Income from operations in the second quarter of fiscal year 2024 decreased by $0.3 million, or 9.0%, when compared to the prior year quarter reflecting lower volume and higher research and development expenses, mostly offset by pricing and productivity initiatives.

Net sales in the six months ended December 31, 2023 decreased by $4.3 million, or 7.5%, when compared to the prior year period. Organic sales decreased by $3.4 million, or 8.1%, partially offset by foreign currency impacts were $0.3 million, or 0.6%, as compared to the prior year period. The net sales decrease was due to project timing partially offset by pricing actions, an increase in new product development in the fast growth commercial space market, and higher sales to the oil and gas market.

Income from operations in the six months ended December 31, 2023 increased by $0.8 million, or 14.6%, when compared to the prior year period. The increase was due to the impact of pricing and productivity initiatives, mostly offset by research and development expenses related to new product development and new applications, partially offset by sales declines due to project timing.

In the third quarter of fiscal year 2024, on a sequential basis, we expect similar revenue reflecting improvement across most end markets, offset by lower defense sales related to delays in government funding, and similar to slightly lower operating margin. We also anticipate significant sequential growth in the fourth quarter of fiscal year 2024 reflecting more favorable project timing.

Net sales in the second quarter of fiscal year 2024 decreased by $12.1 million, or 35.5%, when compared to the prior year quarter. Organic sales for the group decreased $5.0 million, or 14.6%, as compared to the prior year quarter, reflecting an organic sales decline in the Hydraulics business due to an ongoing industry-wide chassis shortage. The divestiture of Procon in the third quarter of fiscal year 2023 negatively impacted the group by $7.1 million, or 20.9%.

Income from operations in the second quarter of fiscal year 2024 decreased $1.8 million or 30.6%, when compared to the prior year quarter, due to the Procon divestiture and lower volume in the Hydraulics business.

Net sales in the six months ended December 31, 2023 decreased by $21.1 million, or 30.7%, when compared to the prior year period. Organic sales for the group decreased $5.4 million, or 7.8%, as compared to the prior year period, reflecting organic growth in the Display Merchandising business, offset by an organic sales decline in the Hydraulics business due to an ongoing industry-wide chassis shortage. The divestiture of Procon in the third quarter of fiscal year 2023 negatively impacted the group by $15.7 million, or 22.9%.

Income from operations in the six months ended December 31, 2023 decreased $2.2 million or 18.7%, when compared to the prior year period, due to the Procon divestiture and lower volume in the Hydraulics business, partially offset by improved operating performance in the Display Merchandising business.

In the third quarter of fiscal year 2024, on a sequential basis, we expect slightly to moderately higher revenue and operating margin due to improved demand in the Hydraulics business.

Corporate expenses in the second quarter of fiscal year 2024 decreased by 4.4% when compared to the prior year quarter. Corporate expenses in the six months ended December 31, 2023 decreased by 2.5% when compared to the prior year period. We expect corporate expenses to increase in the third quarter of fiscal year 2024 reflecting the impact of a charge due to the CEO reaching retirement eligibility under the stock compensation plan.

The restructuring, gain on sale of business and acquisition related costs have been discussed above in the Company Overview.

In pursuing our business strategy, the Company may divest certain businesses. Future divestitures may be classified as discontinued operations based on their strategic significance to the Company. Net loss from discontinued operations was $0.2 million and $0.3 million for the three and six months ended December 31, 2023, respectively.

At December 31, 2023, our total cash balance was $142.4 million, of which $116.7 million was held by foreign subsidiaries. The amount and timing of cash repatriation is dependent upon foreign exchange rates and each business unit’s operational needs including requirements to fund working capital, capital expenditure, and jurisdictional tax payments. The repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to capital controls; however, those balances are generally available without legal restrictions to fund ordinary business operations.

Net cash provided by continuing operating activities for the six months ended December 31, 2023, was $40.2 million compared to net cash provided by continuing operating activities of $27.1 million in the prior year. We generated $56.8 million from income statement activities and used $15.1 million of cash to fund working capital and other balance sheet increases. Cash flow used in investing activities for the six months ended December 31, 2023 totaled $37.5 million and primarily consisted of $29.2 million for the acquisition of Minntronix in the first quarter of fiscal year 2024 and $8.6 million used for capital expenditures offset by $0.3 million proceeds from the prior divestiture of the Procon business. Cash used for financing activities for the six months ended December 31, 2023 totaled $57.3 million and consisted primarily of repayments of debt of $25.0 million, purchases of stock of $26.7 million and cash paid for dividends of $6.8 million.

During the third quarter of fiscal year 2023, the Company entered into a Third Amended & Restated Credit Agreement which renewed the existing Credit Agreement for an additional five-year period (“credit agreement”, or “facility”) with a borrowing limit of $500 million. The facility can be increased by an amount of up to $250 million, in accordance with specified conditions contained in the agreement. The facility also includes a $10 million sublimit for swing line loans and a $35 million sublimit for letters of credit.

Under the terms of the Credit Facility, we pay a variable rate of interest and a commitment fee on borrowed amounts as well as a commitment fee on unused amounts under the facility. The amount of the commitment fee depends upon both the undrawn amount remaining available under the facility and the Company’s funded debt to EBITDA (as defined in the agreement) ratio at the last day of each quarter. As our funded debt to EBITDA ratio increases, the commitment fee increases.

Funds borrowed under the facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio is maintained), and other general corporate purposes. As of December 31, 2023, the Company used $2.9 million against the letter of credit sub-facility and had the ability to borrow $347.1 million under the facility based on our current trailing twelve-month EBITDA. The facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants. The Company’s current financial covenants under the facility are as follows:

Interest Coverage Ratio - The Company is required to maintain a ratio of Earnings Before Interest and Taxes, as Adjusted (“Adjusted EBIT per the Credit Facility”), to interest expense for the trailing twelve months of at least 2.75:1. Adjusted EBIT per the Credit Facility specifically excludes extraordinary and certain other defined items such as cash restructuring and acquisition related charges up to the lower of $20.0 million or 10% of EBITDA. The facility also allows for unlimited non-cash purchase accounting and goodwill adjustments. At December 31, 2023, the Company’s Interest Coverage Ratio was 23.30:1.

Leverage Ratio - The Company’s ratio of funded debt to trailing twelve month Adjusted EBITDA per the Credit Facility, calculated as Adjusted EBIT per the Credit Facility plus depreciation and amortization, may not exceed 3.5:1. Under certain circumstances in connection with a Material Acquisition (as defined in the Facility), the Facility allows for the leverage ratio to go as high as 4.0:1 for a four-fiscal quarter period. At December 31, 2023, the Company’s leverage ratio was 0.65:1.

As of December 31, 2023, we had borrowings under our facility of $150.0 million. In order to manage our interest rate exposure on these borrowings, we are party to $150.0 million of active floating to fixed rate swaps. These swaps convert our interest payments from SOFR to a weighted average fixed rate of 0.85%. The effective rate of interest for our outstanding borrowings, including the impact of the interest rate swaps, was 2.65%.

Our primary cash requirements in addition to day-to-day operating needs include interest payments, capital expenditures, acquisitions, share repurchases, and dividends. Our primary sources of cash for these requirements are cash flows from continuing operations and borrowings under the facility. We expect fiscal year 2024 capital spending to be between $25.0 million and $30.0 million. We expect that fiscal year 2024 depreciation and amortization expense will be between $22.0 million and $25.0 million and $8.0 million and $10.0 million, respectively.

We sponsor a number of defined benefit and defined contribution retirement plans. The U.S. pension plan is frozen for substantially all participants. We have evaluated the current and long-term cash requirements of these plans, and our existing sources of liquidity are expected to be sufficient to cover required contributions under ERISA and other governing regulations.

The fair value of the Company's U.S. defined benefit pension plan assets was $141.3 million at December 31, 2023, as compared to $142.1 million at the most recent measurement date, which occurred as of June 30, 2023. The next measurement date to determine plan assets and benefit obligations will be on June 30, 2024.

The Company expects to pay $8.7 million in contributions to its defined benefit plans during the remainder of fiscal year 2024. Contributions of $1.5 million and $0.1 million were made during the six months ended December 31, 2023 and 2022, respectively. There are required contributions of $9.8 million to the United States funded pension plan for fiscal year 2024. In the second quarter of fiscal year 2024, we contributed $1.4 million and the remaining $8.4 million will be contributed in the second half of fiscal year 2024. The Company expects to make contributions during the remainder of fiscal year 2024 of $0.1 million and $0.3 million to its unfunded defined benefit plans in the U.S. and Germany, respectively. Any subsequent plan contributions will depend on the results of future actuarial valuations.

We have an insurance program in place to fund supplemental retirement income benefits for three retired executives. Current executives and new hires are not eligible for this program. At December 31, 2023, the underlying policies had a cash surrender value of $11.7 million and are reported net of loans of $5.0 million for which we have the legal right of offset, these amounts are reported net on our balance sheet.

Inflation – Certain of our expenses, such as wages and benefits, occupancy costs, freight and equipment repair and replacement, are subject to normal inflationary pressures. Inflation for medical costs can impact both our employee benefit costs as well as our reserves for workers' compensation claims. We monitor the inflationary rate and make adjustments to reserves whenever it is deemed necessary. Our ability to control worker compensation insurance medical cost inflation is dependent upon our ability to manage claims and purchase insurance coverage to limit the maximum exposure for us. Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements. We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices. The ultimate acceptance of these price increases will be impacted by our affected divisions’ respective competitors and the timing of their price increases. In general, we do not enter into purchase contracts that extend beyond one operating cycle. While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.

Foreign Currency Translation – Our primary functional currencies used by our non-U.S. subsidiaries are the Euro, British Pound Sterling (Pound), Japanese (Yen), and Chinese (Yuan).

Defined Benefit Pension Plans – We record expenses related to these plans based upon various actuarial assumptions such as discount rates, mortality rates, and assumed rates of returns. The Company’s pension plan is frozen for substantially all eligible U.S. employees and participants in the plan ceased accruing future benefits.

Environmental Matters – To the best of our knowledge, we believe that we are presently in substantial compliance with all existing applicable environmental laws and regulations and do not anticipate any instances of non-compliance that will have a material effect on our future capital expenditures, earnings or competitive position.

Seasonality – We are a diversified business with generally low levels of seasonality.

Employee Relations – The Company has labor agreements with several union locals in the United States and several European employees belong to European trade unions.

The condensed consolidated financial statements include the accounts of Standex International Corporation and all of its subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying condensed consolidated financial statements. Although we believe that materially different amounts would not be reported due to the accounting policies adopted, the application of certain accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates. Our Annual Report on Form 10-K for the year ended June 30, 2023 lists a number of accounting policies which we believe to be the most critical.

We are exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency exchange. To reduce these risks, we selectively use, from time to time, financial instruments and other proactive management techniques. We have internal policies and procedures that place financial instruments under the direction of the Treasurer and restrict all derivative transactions to those intended for hedging purposes only. The use of financial instruments for trading purposes (except for certain investments in connection with the non-qualified defined contribution plan) or speculation is strictly prohibited. The Company has no majority-owned subsidiaries that are excluded from the consolidated financial statements. Further, we have no interests in or relationships with any special purpose entities.

We are exposed to both transactional risk and translation risk associated with exchange rates. The transactional risk is mitigated, in large part, by natural hedges developed with locally denominated debt service on intercompany accounts. We also mitigate certain of our foreign currency exchange rate risks by entering into forward foreign currency contracts from time to time. The contracts are used as a hedge against anticipated foreign cash flows, such as loan payments, customer remittances, and materials purchases, and are not used for trading or speculative purposes. The fair values of the forward foreign currency exchange contracts are sensitive to changes in foreign currency exchange rates, as an adverse change in foreign currency exchange rates from market rates would decrease the fair value of the contracts. However, any such losses or gains would generally be offset by corresponding gains and losses, respectively, on the related hedged asset or liability. At December 31, 2023 the fair value, in the aggregate, of the Company’s open foreign exchange contracts was an asset of $0.6 million.

Our primary translation risk is with the Euro, British Pound Sterling, Peso, Japanese Yen and Chinese Yuan. A hypothetical 10% appreciation or depreciation of the value of any these foreign currencies to the U.S. Dollar at December 31, 2023, would not result in a material change in our operations, financial position, or cash flows. We hedge our most significant foreign currency translation risks primarily through cross currency swaps and other instruments, as appropriate.

The Company’s effective interest rate on borrowings was 2.65% at December 31, 2023. Our interest rate exposure is limited primarily to interest rate changes on our variable rate borrowings and is mitigated by our use of interest rate swap agreements to modify our exposure to interest rate movements. At December 31, 2023, we have $150.0 million of active floating to fixed rate swaps with terms through fiscal year 2025. These swaps convert our interest payments from SOFR to a weighted average rate of 0.85%. At December 31, 2023 the fair value, in the aggregate, of the Company’s interest rate swaps was assets of $6.7 million. A 25-basis point increase in interest rates would not materially change our annual interest expense as most of our outstanding debt is currently converted to fixed rate debts by means of interest rate swaps.

We have a diversified customer base. As such, the risk associated with concentration of credit risk is inherently minimized. As of December 31, 2023, no one customer accounted for more than 5% of our consolidated outstanding receivables or of our sales.

The Company is exposed to fluctuating market prices for all commodities used in its manufacturing processes. Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements. In general, we do not enter into purchase contracts that extend beyond one operating cycle. While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.

The Engineering Technologies, Specialty Solutions, and Electronics segments are all sensitive to price increases for steel and aluminum products, other metal commodities such as rhodium and copper, and petroleum-based products. We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices. The ultimate acceptance of these price increases, if implemented, will be impacted by our affected divisions’ respective competitors and the timing of their price increases.

At the end of the period covered by this Report, the management of the Company, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2023 in ensuring that the information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's ("SEC") rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There was no change in the Company's internal control over financial reporting during the quarterly period ended December 31, 2023 that has materially affected or is reasonably likely to materially affect the Company's internal control over financial reporting.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	*Preliminary Allocation December 31, 2023*
Fair value of business combination:
Cash payments	$	33,890
Less, cash acquired		(4,661	)
Total	$	29,229

	*Preliminary Allocation December 31, 2023*
Identifiable assets acquired and liabilities assumed:
Other acquired assets	$	8,282
Customer backlog		1,120
Inventories		1,780
Property, plant, & equipment		1,039
Identifiable intangible assets		10,700
Goodwill		13,889
Liabilities assumed		(7,581	)
Total	$	29,229

	*Three Months Ended*
Revenue by Product Line	*December 31, 2023*		*December 31, 2022*

Electronics	$	79,419	$	72,556

Engraving Services		38,467		36,221
Engraving Products		2,378		1,468
Total Engraving		40,845		37,689

Scientific		16,292		19,292

Engineering Technologies		19,887		24,193

Hydraulics Cylinders and Systems		11,881		17,538
Merchandising & Display		10,076		9,392
Pumps		-		7,129
Total Specialty Solutions		21,957		34,059

Total revenue by product line	$	178,400	$	187,789

	*Six Months Ended*
Revenue by Product Line	*December 31, 2023*		*December 31, 2022*

Electronics	$	161,107	$	147,755

Engraving Services		77,203		69,805
Engraving Products		4,436		2,908
Total Engraving		81,639		72,713

Scientific		34,485		37,748

Engineering Technologies		38,107		41,192

Hydraulics Cylinders and Systems		26,610		34,275
Merchandising & Display		21,226		18,957
Pumps		-		15,749
Total Specialty Solutions		47,836		68,981

Total revenue by product line	$	363,174	$	368,389

	*Three Months Ended*		*Three Months Ended*		*Six Months Ended*		*Six Months Ended*
Net sales	*December 31, 2023*		*December 31, 2022*		*December 31, 2023*		*December 31, 2022*
United States	$	110,167	$	116,303	$	224,668	$	226,462
Asia Pacific		32,742		33,861		64,151		66,654
EMEA (1)		31,632		33,401		66,100		67,326
Other Americas		3,859		4,224		8,255		7,947
Total	$	178,400	$	187,789	$	363,174	$	368,389

	*Three Months Ended*
Timing of Revenue Recognition	*December 31, 2023*		*December 31, 2022*
Products and services transferred at a point in time	$	160,204	$	165,728
Products transferred over time		18,196		22,061
Net sales	$	178,400	$	187,789

	*Balance at Beginning of Period*		*Additions*		*Deductions*		*Balance at End of Period*
Six months ended December 31, 2023
Contract assets:
Prepaid expenses and other current assets	$	31,138	$	33,565	$	30,201	$	34,502

	December 31, 2022		December 31, 2022
Revenue recognized in the period from:	*Three months ended*		*Six months ended*
Amounts included in the contract liability balance at the beginning of the period	$	38	$	41

	*December 31, 2023*
	*Total*		*Level 1*		*Level 2*		*Level 3*
Assets
Marketable securities - deferred compensation plan	$	4,431	$	4,431	$	-	$	-
Foreign exchange contracts		601		-		601		-
Interest rate swaps		6,677		-		6,677		-
Debt securities		2,760		-		-		2,760
Equity securities		2,070		-		-		2,070

Liabilities
Foreign exchange contracts	$	-	$	-	$	-	$	-

	*June 30, 2023*
	*Total*		*Level 1*		*Level 2*		*Level 3*
Assets
Marketable securities - deferred compensation plan	$	3,720	$	3,720	$	-	$	-
Interest rate swaps		10,235		-		10,235		-
Debt securities		2,729		-		-		2,729
Equity securities		2,046		-		-		2,046

Liabilities
Foreign exchange contracts	$	1,722	$	-	$	1,722	$	-

	*December 31, 2023*		*June 30, 2023*
Raw materials	$	47,521	$	45,268
Work in process		18,065		20,389
Finished goods		33,006		32,880
Total	$	98,592	$	98,537

	*June 30, 2023*		*Acquisitions*		*Translation Adjustment*		*December 31, 2023*
Electronics	$	133,432	$	13,889	$	1,504	$	148,825
Engraving		76,583		-		100		76,683
Scientific		15,454		-		-		15,454
Engineering Technologies		36,293		-		23		36,316
Specialty Solutions		3,059		-		-		3,059
Total	$	264,821	$	13,889	$	1,627	$	280,337

	*December 31, 2023*			*June 30, 2023*
Balance at beginning of year	$	2,094		$	1,918
Acquisitions and other charges		92			-
Warranty expense		1,139			1,939
Warranty claims		(894	)		(1,763	)
Balance at end of period	$	2,431		$	2,094

	*December 31, 2023*			*June 30, 2023*
Bank credit agreements	$	150,000		$	175,000
Total funded debt		150,000			175,000
Issuance cost		(1,341	)		(1,559	)
Total long-term debt	$	148,659		$	173,441

	*December 31, 2023*		*June 30, 2023*
Payroll and employee benefits	$	22,764	$	30,778
Operating lease current liability		8,701		8,036
Warranty reserves		2,431		2,094
Restructuring costs		1,642		1,296
Workers' compensation		1,598		1,516
Fair value of derivatives		-		1,722
Other		18,926		16,589
Total	$	56,062	$	62,031

Effective Date	*Notional Amount*	*Fixed Interest Rate*	*Maturity*	*December 31, 2023*		*June 30, 2023*
February 6, 2023	25,000	2.80%	August 6, 2023	$	-	$	59
February 23, 2023	100,000	0.86%	March 23, 2025		4,394		6,716
April 24, 2020	25,000	0.88%	April 24, 2025		1,181		1,777
February 24, 2023	25,000	0.86%	March 24, 2025		1,102		1,683
				$	6,677	$	10,235

Currency	*December 31, 2023*		*June 30, 2023*
CAD		-		16,600
JPY		4,200,000		2,100,000

	*Asset Derivatives*
	*December 31, 2023*			*June 30, 2023*
Derivative designated	*Balance*			*Balance*
as hedging instruments	*Sheet*			*Sheet*
	*Line Item*	*Fair Value*		*Line Item*	*Fair Value*
Interest rate swaps	Prepaid expenses and other current assets	$	6,677	Prepaid expenses and other current assets	$	10,235
		$	6,677		$	10,235

	*Liability Derivatives*
	*December 31, 2023*			*June 30, 2023*
Derivative designated	*Balance*			*Balance*
as hedging instruments	*Sheet*			*Sheet*
	*Line Item*	*Fair Value*		*Line Item*	*Fair Value*
Foreign exchange contracts	Accrued liabilities	$	-	Accrued liabilities	$	315
		$	-		$	315

Details about Accumulated													*Affected line item*
Other Comprehensive	*Three Months Ended*						*Six Months Ended*						*in the Unaudited*
Income (Loss) Components	*December 31,*						*December 31,*						*Condensed Statements*
	*2023*			*2022*			*2023*			*2022*			*of Operations*
Interest rate swaps	$	(1,713	)	$	(1,105	)	$	(3,433	)	$	(1,559	)	Interest expense
Foreign exchange contracts		-			599			(215	)		1,095		Other non-operating (income) expense, net
	$	(1,713	)	$	(506	)	$	(3,648	)	$	(464	)

	*U.S. Plans*						*Non-U.S. Plans*
	*Three Months Ended*						*Three Months Ended*
	*December 31,*						*December 31,*
	*2023*			*2022*			*2023*			*2022*
Service cost	$	-		$	-		$	40		$	43
Interest cost		2,473			2,396			292			263
Expected return on plan assets		(2,779	)		(2,994	)		(346	)		(247	)
Recognized net actuarial loss		951			954			(150	)		(16	)
Amortization of prior service cost		-			-			(1	)		(1	)
Net periodic (benefit) cost	$	645		$	356		$	(165	)	$	42

Amounts recognized in the consolidated balance sheets consist of:	*December 31, 2023*			*June 30, 2023*
Prepaid benefit cost	$	3,019		$	2,807
Current liabilities		(502	)		(425	)
Non-current liabilities		(46,054	)		(48,154	)
Net amount recognized	$	(43,537	)	$	(45,772	)

	*Fiscal Year 2024*		*Remaining*
	*Six Months Ended*		*Contributions*
Contributions to defined benefit plans	*December 31, 2023*		*FY 2024*
United States, funded plan	$	1,442	$	8,363
United States, unfunded plan		99		53
United Kingdom		-		-
Germany, unfunded plan		-		255
	$	1,541	$	8,671

	•	Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum;
	•	Engraving – provides mold texturizing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries;
	•	Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets;
	•	Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets;
	•	Specialty Solutions – an aggregation of two operating segments that manufacture and sell refrigerated, heated and dry merchandizing display cases and single and double acting telescopic and piston rod hydraulic cylinders.

	*Three Months Ended December 31,*
	*Net Sales*				*Income from Operations*
	*2023*		*2022*		*2023*			*2022*
Industry segment:
Electronics	$	79,419	$	72,556	$	15,850		$	16,972
Engraving		40,845		37,689		8,910			6,373
Scientific		16,292		19,292		4,248			4,165
Engineering Technologies		19,887		24,193		3,405			3,741
Specialty Solutions		21,957		34,059		3,965			5,716
Corporate		-		-		(7,991	)		(8,360	)
Restructuring costs		-		-		(1,360	)		(511	)
Gain on sale of business		-		-		-			-
Acquisition related costs		-		-		(1,195	)		(174	)
Other operating income (expense), net		-		-		-			(116	)
Sub-total	$	178,400	$	187,789	$	25,832		$	27,806
Interest expense						1,019			1,566
Other non-operating (income) expense						332			(70	)
Income from continuing operations before income taxes					$	24,481		$	26,310

	*Six Months Ended December 31,*
	*Net Sales*				*Income from Operations*
	*2023*		*2022*		*2023*			*2022*
Industry segment:
Electronics	$	161,107	$	147,755	$	32,184		$	35,113
Engraving		81,639		72,713		16,505			12,227
Scientific		34,485		37,748		9,178			7,888
Engineering Technologies		38,107		41,192		6,422			5,606
Specialty Solutions		47,836		68,981		9,582			11,793
Corporate		-		-		(16,434	)		(16,856	)
Restructuring costs		-		-		(3,266	)		(1,093	)
Gain on sale of business		-		-		274			-
Acquisition related costs		-		-		(1,696	)		(466	)
Other operating income (expense), net		-		-		-			(116	)
Sub-total	$	363,174	$	368,389	$	52,749		$	54,096
Interest expense						2,295			2,753
Other non-operating (income) expense						1,178			948
Income from continuing operations before income taxes					$	49,276		$	50,395

Current Year Initiatives	*Involuntary Employee Severance and Benefit Costs*			*Other*			*Total*
Restructuring liabilities at June 30, 2023	$	-		$	-		$	-
Additions and adjustments		1,786			1,252			3,038
Payments		(843	)		(1,029	)		(1,872	)
Restructuring liabilities at December 31, 2023	$	943		$	223		$	1,166

Prior Year Initiatives	*Involuntary Employee Severance and Benefit Costs*			*Other*			*Total*
Restructuring liabilities at June 30, 2023	$	1,104		$	192		$	1,296
Additions and adjustments		182			46			228
Payments		(985	)		(63	)		(1,048	)
Restructuring liabilities at December 31, 2023	$	301		$	175		$	476

	Three Months Ended						Six Months Ended
	December 31,						December 31,
(In thousands, except percentages)	2023			2022			2023			2022
Net sales	$	178,400		$	187,789		$	363,174		$	368,389
Gross profit margin		40.2	%		38.5	%		39.7	%		38.2	%
Income from operations		25,832			27,806			52,749			54,096

	As of December 31, 2023				As of December 31, 2022
	Total Backlog		Backlog under 1 year		Total Backlog		Backlog under 1 year
Electronics	$	126,127	$	111,977	$	170,754	$	153,504
Engraving		28,828		25,333		27,947		17,677
Scientific		3,000		3,000		3,909		3,909
Engineering Technologies		67,386		52,348		69,853		53,975
Specialty Solutions		16,908		16,641		44,442		39,577
Total	$	242,249	$	209,299	$	316,905	$	268,642

	As of
(In thousands)	December 31, 2023
Backlog under 1 year, prior year period	$	268,642
Components of change in backlog:
Organic change		(64,339	)
Effect of acquisitions		11,203
Effect of divestitures		(6,207	)
Backlog under 1 year, current period	$	209,299

	●	vaccine storage demand to remain stable after the record COVID-19 related surge in fiscal year 2021 and early fiscal year 2022;
	●	commercial aviation and defense end markets demand to increase based on current program expectations;

	●	refuse and dump end markets to improve;
	●	slightly lower demand levels in food service equipment markets;
	●	market softness in China and Europe, including inventory destocking, affecting general industrial and appliances end markets served by our Electronics Group.

(In thousands)	December 31, 2023			June 30, 2023
Long-term debt	$	148,659		$	173,441
Less cash and cash equivalents		(142,424	)		(195,706	)
Net (cash) debt		6,235			(22,265	)
Stockholders' equity		620,571			607,449
Total capitalization	$	626,806		$	585,184

Period	(a) Total number of shares (or units) purchased		(b) Average price paid per share (or unit)		(c) Total number of shares (or units) purchased as part of publicly announced plans or programs		(d) Maximum number (or appropriate dollar value) of shares (or units) that may yet be purchased under the plans or programs
October 1, 2023 - October 31, 2023		59	$	151.32		59	$	42,957

November 1, 2023 - November 30, 2023		31,656		136.40		31,656		38,749

December 1, 2023 - December 31, 2023		1,735		158.38		1,735		38,474

Total		33,450	$	137.60		33,450	$	38,474

	31.1	Principal Executive Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	31.2	Principal Financial Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32	Principal Executive Officer and Principal Financial Officer Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
	101	The following materials from this Quarterly Report on Form 10-Q, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
	104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).


		STANDEX INTERNATIONAL CORPORATION

Date:	February 2, 2024	/s/ ADEMIR SARCEVIC
		Ademir Sarcevic
		Vice President/Chief Financial Officer
		(Principal Financial & Accounting Officer)

Date:	February 2, 2024	/s/ AMY GAGNON
		Amy Gagnon
		Vice President/Chief Accounting Officer

Dated: February 2, 2024	/s/ David Dunbar

	David Dunbar
	Chief Executive Officer




Dated: February 2, 2024	/s/ Ademir Sarcevic

	Ademir Sarcevic
	Chief Financial Officer

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Dec. 31, 2023	Jan. 31, 2024
Document Information [Line Items]
Entity Central Index Key	0000310354
Entity Registrant Name	STANDEX INTERNATIONAL CORP/DE/
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-07233
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-0596149
Entity Address, Address Line One	23 Keewaydin drive
Entity Address, City or Town	Salem
Entity Address, State or Province	NH
Entity Address, Postal Zip Code	03079
City Area Code	603
Local Phone Number	893-9701
Title of 12(b) Security	Common Stock, Par Value $1.50 Per Share
Trading Symbol	SXI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,870,622